SCHEMBL3640203

SCHEMBL3640203

O=C(O)n1cc2ccccc2c1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.38
MEN1 O00255 5/20 0.38
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 2/20 0.38
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38
CYP1A2 P05177 1/20 0.38
GLA P06280 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
WDR5 P61964 1/20 0.36
LDHA P00338 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
CDC25B P30305 1/20 0.34
RAB9A P51151 2/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18986766 0.78 LDHA (0.40) KMT2AMEN1KDM4EALDH1A1NR4A1
SCHEMBL30561525 0.77 HSD17B10 (0.38) KMT2AMEN1KDM4EALDH1A1NR4A1
SCHEMBL7209262 0.66 KMT2A (0.47) KMT2AMEN1KDM4EALDH1A1CYP1A2
SCHEMBL447966 0.65 NOTUM (0.47) KMT2AMEN1KDM4EALDH1A1HPGD
SCHEMBL9697347 0.64 FDPS (0.45) KDM4EALDH1A1NR4A1NR4A2NR4A3
Acetic Acid SCHEMBL27635426 0.64 MEN1 (0.51) KMT2AMEN1KDM4EALDH1A1NR4A1
Naphthalene SCHEMBL14715817 0.64 CYP2A6 (0.50) KMT2AMEN1KDM4EALDH1A1NR4A1
SCHEMBL3830527 0.63 ALDH1A1 (0.43) KMT2AMEN1KDM4EALDH1A1NR4A1
Phenanthrene SCHEMBL11152558 0.63 ALDH1A1 (0.63) KMT2AMEN1KDM4EALDH1A1NR4A1
SCHEMBL2075524 0.63 ALDH1A1 (0.38) KMT2AMEN1KDM4EALDH1A1NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2237666-A1 HCV PROTEASE INHIBITORS AND USES THEREOF Avila Therapeutics, Inc. (US) 2010-10-13 EP disclosed
EP-2160392-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2010-03-10 EP disclosed
WO-2009082701-A1 HCV PROTEASE INHIBITORS AND USES THEREOF AVILA THERAPEUTICS, INC. (US) 2009-07-02 WO disclosed
WO-2008137779-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2008-11-13 WO disclosed
EP-1924594-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION Intermune, Inc. (US) 2008-05-28 EP disclosed
WO-2007015824-A2 NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION INTERMUNE, INC. (US) 2007-02-08 WO disclosed